{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:07:02Z","timestamp":1792814822018,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073141"],"award-info":[{"award-number":["82073141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572800"],"award-info":[{"award-number":["81572800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR22H160006"],"award-info":[{"award-number":["LR22H160006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY15H160041"],"award-info":[{"award-number":["LY15H160041"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Human thymic epithelial tumors (TET) are common malignancies in the anterior mediastinum with limited biological understanding. Here we show, by single cell analysis of the immune landscape, that the developmental pattern of intra-tumoral T-cells identify three types within TETs. We characterize the developmental alterations and TCR repertoires of tumor-infiltrating T cells in the context of the distinguishing epithelial tumor cell types. We demonstrate that a subset of tumor cells, featuring medullary thymic epithelial cell (TEC) phenotype and marked by\n                    <jats:italic>KRT14\/GNB3<\/jats:italic>\n                    expression, accumulate in type 1 TETs, while T-cell positive selection is inhibited. Type 2 TETs are dominated by\n                    <jats:italic>CCL25<\/jats:italic>\n                    <jats:sup>+<\/jats:sup>\n                    cortical TEC-like cells that appear to promote T-cell positive selection. Interestingly, the\n                    <jats:italic>CHI3L1<\/jats:italic>\n                    <jats:sup>+<\/jats:sup>\n                    medullary TEC-like cells that are the characteristic feature of type 3 TETs don\u2019t seem to support T-cell development, however, they may induce a tissue-resident CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell response. In summary, our work suggests that the molecular subtype of epithelial tumour cells in TETs determine their tumour immune microenvironment, thus\n                    <jats:italic>GNB3<\/jats:italic>\n                    and\n                    <jats:italic>CHI3L1<\/jats:italic>\n                    might predict the immunological behavior and hence prognosis of these tumours.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-33170-7","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T07:05:40Z","timestamp":1663398340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The immune landscape of human thymic epithelial tumors"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-428X","authenticated-orcid":false,"given":"Zhongwei","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-050X","authenticated-orcid":false,"given":"Ying","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-1425","authenticated-orcid":false,"given":"Pin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"33170_CR1","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels, E. A. Epidemiology of thymoma and associated malignancies. J. Thorac. Oncol. 5, S260\u2013S265 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"33170_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"de Jong, W. K. et al. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur. J. Cancer 44, 123\u2013130 (2008).","journal-title":"Eur. J. Cancer"},{"key":"33170_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","volume":"270","author":"A Marx","year":"2015","unstructured":"Marx, A. et al. Thymoma related myasthenia gravis in humans and potential animal models. Exp. Neurol. 270, 55\u201365 (2015).","journal-title":"Exp. Neurol."},{"key":"33170_CR4","first-page":"316","volume":"3","author":"B Huang","year":"2013","unstructured":"Huang, B. et al. Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c. Front Oncol. 3, 316 (2013).","journal-title":"Front Oncol."},{"key":"33170_CR5","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/ijc.23335","volume":"122","author":"V Ehemann","year":"2008","unstructured":"Ehemann, V. et al. Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma. Int J. Cancer 122, 2719\u20132725 (2008).","journal-title":"Int J. Cancer"},{"key":"33170_CR6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/labinvest.2012.115","volume":"92","author":"Y Gokmen-Polar","year":"2012","unstructured":"Gokmen-Polar, Y. et al. Establishment and characterization of a novel cell line derived from human thymoma AB tumor. Lab Invest 92, 1564\u20131573 (2012).","journal-title":"Lab Invest"},{"key":"33170_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx, A. et al. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J. Thorac. Oncol. 10, 1383\u20131395 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"33170_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel, P. et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J. Clin. Oncol. 22, 1501\u20131509 (2004).","journal-title":"J. Clin. Oncol."},{"key":"33170_CR9","doi-asserted-by":"publisher","first-page":"102014","DOI":"10.1016\/j.ctrv.2020.102014","volume":"86","author":"F Conforti","year":"2020","unstructured":"Conforti, F., Pala, L., Giaccone, G. & De Pas, T. Thymic epithelial tumors: From biology to treatment. Cancer Treat. Rev. 86, 102014 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"33170_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-immunol-051116-052320","volume":"35","author":"J Abramson","year":"2017","unstructured":"Abramson, J. & Anderson, G. Thymic Epithelial Cells. Annu Rev. Immunol. 35, 85\u2013118 (2017).","journal-title":"Annu Rev. Immunol."},{"key":"33170_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev-immunol-042718-041319","volume":"37","author":"A Cumano","year":"2019","unstructured":"Cumano, A. et al. New Molecular Insights into Immune Cell Development. Annu Rev. Immunol. 37, 497\u2013519 (2019).","journal-title":"Annu Rev. Immunol."},{"key":"33170_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.immunol.21.120601.141107","volume":"21","author":"TK Starr","year":"2003","unstructured":"Starr, T. K., Jameson, S. C. & Hogquist, K. A. Positive and negative selection of T cells. Annu Rev. Immunol. 21, 139\u2013176 (2003).","journal-title":"Annu Rev. Immunol."},{"key":"33170_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/cmi.2010.74","volume":"8","author":"S Shelly","year":"2011","unstructured":"Shelly, S., Agmon-Levin, N., Altman, A. & Shoenfeld, Y. Thymoma and autoimmunity. Cell Mol. Immunol. 8, 199\u2013202 (2011).","journal-title":"Cell Mol. Immunol."},{"key":"33170_CR14","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1097\/JTO.0000000000000299","volume":"9","author":"B Weksler","year":"2014","unstructured":"Weksler, B. & Lu, B. Alterations of the immune system in thymic malignancies. J. Thorac. Oncol. 9, S137\u2013S142 (2014).","journal-title":"J. Thorac. Oncol."},{"key":"33170_CR15","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1158\/1078-0432.CCR-17-0066","volume":"23","author":"HS Lee","year":"2017","unstructured":"Lee, H. S. et al. Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 23, 4855\u20134864 (2017).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"33170_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","volume":"33","author":"M Radovich","year":"2018","unstructured":"Radovich, M. et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell 33, 244\u2013258.e210 (2018).","journal-title":"Cancer Cell"},{"key":"33170_CR17","unstructured":"Park, J. E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, eaay3224 (2020)."},{"key":"33170_CR18","doi-asserted-by":"crossref","unstructured":"Masopust D. & Soerens A. G. Tissue-Resident T Cells and Other Resident Leukocytes. Ann. Rev. Immunol. 37, 521\u2013546 (2019).","DOI":"10.1146\/annurev-immunol-042617-053214"},{"key":"33170_CR19","first-page":"75","volume":"360","author":"T Taghon","year":"2012","unstructured":"Taghon, T., Waegemans, E. & Van de Walle, I. Notch signaling during human T cell development. Curr. Top. Microbiol Immunol. 360, 75\u201397 (2012).","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"33170_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/sj.leu.2404255","volume":"20","author":"F Weerkamp","year":"2006","unstructured":"Weerkamp, F., van Dongen, J. J. & Staal, F. J. Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia 20, 1197\u20131205 (2006).","journal-title":"Leukemia"},{"key":"33170_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.mad.2006.01.016","volume":"127","author":"R Aspinall","year":"2006","unstructured":"Aspinall, R. T cell development, ageing and Interleukin-7. Mech. Ageing Dev. 127, 572\u2013578 (2006).","journal-title":"Mech. Ageing Dev."},{"key":"33170_CR22","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.celrep.2017.05.045","volume":"19","author":"ZM Carico","year":"2017","unstructured":"Carico, Z. M., Roy Choudhury, K., Zhang, B., Zhuang, Y. & Krangel, M. S. Tcrd Rearrangement Redirects a Processive Tcra Recombination Program to Expand the Tcra Repertoire. Cell Rep. 19, 2157\u20132173 (2017).","journal-title":"Cell Rep."},{"key":"33170_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-018-0345-2","volume":"559","author":"CN Miller","year":"2018","unstructured":"Miller, C. N. et al. Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. Nature 559, 627\u2013631 (2018).","journal-title":"Nature"},{"key":"33170_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41586-018-0346-1","volume":"559","author":"C Bornstein","year":"2018","unstructured":"Bornstein, C. et al. Single-cell mapping of the thymic stroma identifies IL-25-producing tuft epithelial cells. Nature 559, 622\u2013626 (2018).","journal-title":"Nature"},{"key":"33170_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41577-019-0238-0","volume":"20","author":"N Kadouri","year":"2020","unstructured":"Kadouri, N., Nevo, S., Goldfarb, Y. & Abramson, J. Thymic epithelial cell heterogeneity: TEC by TEC. Nat. Rev. Immunol. 20, 239\u2013253 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"33170_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00281-021-00842-3","volume":"43","author":"A Marx","year":"2021","unstructured":"Marx, A. et al. Thymus and autoimmunity. Semin. Immunopathol. 43, 45\u201364 (2021).","journal-title":"Semin. Immunopathol."},{"key":"33170_CR27","doi-asserted-by":"crossref","unstructured":"Chia R. et al. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study. Proc Natl Acad Sci USA 119, e2108672119 (2022).","DOI":"10.1073\/pnas.2206754119"},{"key":"33170_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/icb.2010.142","volume":"89","author":"MD Bunting","year":"2011","unstructured":"Bunting, M. D., Comerford, I. & McColl, S. R. Finding their niche: chemokines directing cell migration in the thymus. Immunol. Cell Biol. 89, 185\u2013196 (2011).","journal-title":"Immunol. Cell Biol."},{"key":"33170_CR29","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.immuni.2020.10.024","volume":"53","author":"LB Chopp","year":"2020","unstructured":"Chopp, L. B. et al. An Integrated Epigenomic and Transcriptomic Map of Mouse and Human alphabeta T Cell Development. Immunity 53, 1182\u20131201.e1188 (2020).","journal-title":"Immunity"},{"key":"33170_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330 (2017).","journal-title":"Nature"},{"key":"33170_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","volume":"37","author":"D Masopust","year":"2019","unstructured":"Masopust, D. & Soerens, A. G. Tissue-Resident T Cells and Other Resident Leukocytes. Annu Rev. Immunol. 37, 521\u2013546 (2019).","journal-title":"Annu Rev. Immunol."},{"key":"33170_CR32","doi-asserted-by":"crossref","unstructured":"Oramas D. M.,& Moran C. A. Thymoma: Histologically a heterogenous group of tumors. Semin Diagn Pathol 39, 99\u2013104 (2021).","DOI":"10.1053\/j.semdp.2021.06.002"},{"key":"33170_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-305","volume":"8","author":"GY Lee","year":"2007","unstructured":"Lee, G. Y. et al. Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genomics 8, 305 (2007).","journal-title":"BMC Genomics"},{"key":"33170_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ng.3016","volume":"46","author":"I Petrini","year":"2014","unstructured":"Petrini, I. et al. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat. Genet. 46, 844\u2013849 (2014).","journal-title":"Nat. Genet."},{"key":"33170_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/carcin\/bgx094","volume":"38","author":"M Saito","year":"2017","unstructured":"Saito, M. et al. The genomic and epigenomic landscape in thymic carcinoma. Carcinogenesis 38, 1084\u20131091 (2017).","journal-title":"Carcinogenesis"},{"key":"33170_CR36","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1038\/s41418-020-0502-7","volume":"27","author":"IK Kim","year":"2020","unstructured":"Kim, I. K. et al. Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells. Cell death Differ. 27, 2263\u20132279 (2020).","journal-title":"Cell death Differ."},{"key":"33170_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/JTO.0000000000000393","volume":"10","author":"CA Weis","year":"2015","unstructured":"Weis, C. A. et al. The impact of thymoma histotype on prognosis in a worldwide database. J. Thorac. Oncol. 10, 367\u2013372 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"33170_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/JTO.0000000000000482","volume":"10","author":"AC Roden","year":"2015","unstructured":"Roden, A. C. et al. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications. J. Thorac. Oncol. 10, 691\u2013700 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"33170_CR39","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jtcvs.2020.10.131","volume":"161","author":"U Ahmad","year":"2021","unstructured":"Ahmad, U. The eighth edition TNM stage classification for thymic tumors: What do I need to know? J. Thorac. Cardiovasc Surg. 161, 1524\u20131529 (2021).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"33170_CR40","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41596-018-0016-7","volume":"13","author":"G Han","year":"2018","unstructured":"Han, G., Spitzer, M. H., Bendall, S. C., Fantl, W. J. & Nolan, G. P. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry. Nat. Protoc. 13, 2121\u20132148 (2018).","journal-title":"Nat. Protoc."},{"key":"33170_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine, J. H. et al. Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis. Cell 162, 184\u2013197 (2015).","journal-title":"Cell"},{"key":"33170_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","volume":"31","author":"E-aD Amir","year":"2013","unstructured":"Amir, E.-aD. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545\u2013552 (2013).","journal-title":"Nat. Biotechnol."},{"key":"33170_CR43","first-page":"1888","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive Integration of Single-. Cell Data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell Data. Cell"},{"key":"33170_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"33170_CR45","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"33170_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"33170_CR47","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"33170_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","volume":"563","author":"R Vento-Tormo","year":"2018","unstructured":"Vento-Tormo, R. et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature 563, 347\u2013353 (2018).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33170-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T08:04:55Z","timestamp":1663401895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33170-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33170"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33170-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-863052\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5463"}}